Okay, let's tackle this question. The patient is a 56-year-old woman with weight loss, abdominal enlargement, a family history of breast and ovarian cancer, and a left adnexal mass. The ultrasound shows a cystic mass with peritoneal nodules and ascites, and the peritoneal fluid has malignant cells. The question is asking which mutated gene is most likely involved here.

First, I need to think about the possible cancers. The symptoms and family history point towards ovarian cancer, especially since the mass is in the adnexal region. Ovarian cancer often presents with abdominal distension, weight loss, and ascites. The family history of breast and ovarian cancer is a red flag for hereditary cancer syndromes. The most common genes associated with hereditary breast and ovarian cancer are BRCA1 and BRCA2.

Now, considering the options (even though they're not listed here), the correct gene would be BRCA1 or BRCA2. But which one is more commonly associated with ovarian cancer? I remember that BRCA1 mutations are more strongly linked to ovarian cancer compared to BRCA2. However, both can contribute. But wait, there's also other genes like TP53, which is associated with Li-Fraumeni syndrome and might lead to various cancers, including breast and ovarian. But the question is about the most likely gene in this context.

Wait, the patient has a family history of breast and ovarian cancer. That's classic for BRCA1 or BRCA2. The presence of peritoneal nodules and ascites with malignant cells suggests advanced ovarian cancer. So the most likely mutated gene here is BRCA1 or BRCA2. Since the options aren't provided, but in standard questions like this, BRCA1 is often the answer. Alternatively, maybe TP53 if it's a different context. But given the family history and the type of cancer, BRCA1 is more likely.

Wait, another angle: The question mentions a cystic mass. Ovarian tumors can be benign or malignant. The presence of malignant cells in ascites points to a high-grade serous carcinoma, which is often associated with BRCA mutations. So BRCA1 or BRCA2. Since the options are not given, but in typical exam settings, BRCA1 is more frequently cited in ovarian cancer. Also, BRCA1 is linked to both breast and ovarian cancers, which fits the family history here.

The other possible genes could be BRCA2, but it's less specific to ovarian cancer compared to BRCA1. There's also the possibility of other genes like PTEN (Cowden syndrome) or MLH1 (Lynch syndrome), but those are more associated with endometrial and colorectal cancers. So the most likely answer here is BRCA1.

**Core Concept**
This question tests knowledge of hereditary cancer syndromes and their associated genes, particularly in ovarian cancer. BRCA1 and BRCA2 mutations are central to hereditary breast and ovarian cancer (HBOC) syndrome, while other genes like TP53 (Li-Fraumeni) or MLH1 (Lynch) are less specific for this context. The clinical presentation of advanced ovarian cancer with a family history strongly implicates BRCA mutations.

**Why the Correct Answer is Right**
The patient’s advanced ovarian cancer (left adnexal mass,

✓ Correct Answer: A. BRCA1